European drug regulators safety panel recommends adding “heavy menstrual bleeding” to mRNA vaccines

It has been much speculated that women started to experience longer periods or excessive bleeding after being exposed to the Covid-19 mRNA vaccine and the VAERS report will also conclude that.

Now the European drug regulator's safety panel recommends adding "heavy menstrual bleeding" as a side effect of Pfizer and Moderna's mRNA injections.

"The PRAC has recommended that heavy menstrual bleeding should be added to the product information as a side effect of unknown frequency of the mRNA COVID-19 vaccines Comirnaty and Spikevax.

Heavy menstrual bleeding (heavy periods) may be defined as bleeding characterised by an increased volume and/or duration which interferes with the person’s physical, social, emotional and material quality of life. Cases of heavy menstrual bleeding have been reported after the first, second and booster doses of Comirnaty and Spikevax."

Official link: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-24-27-october-2022